ba0002p80 | (1) | ICCBH2013
Cardinal Mickael
, Nyssen-Behets Catherine
, Ominsky Mike
, Devogelaer Jean-Pierre
, Manicourt Daniel H
Introduction: Osteogenesis imperfecta (OI) is characterized by low bone mass, skeletal fragility and, frequently, short stature. We previously showed in oim/oim mice that sclerostin inhibition increased bone mass, mineral content and strength. Here, we compared the body length and the sizes of long bones, head and vertebrae between oim/oim and wildtype mice and analyzed the effect of sclerostin antibody (Scl-Ab) on these parameters.Materials and methods:...